All Stories

  1. Low iron-induced small RNA BrrF regulates central metabolism and oxidative stress responses in Burkholderia cenocepacia
  2. Laser-induced vapour nanobubbles improve drug diffusion and efficiency in bacterial biofilms
  3. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics
  4. Developing an in vitro artificial sebum model to study Propionibacterium acnes biofilms
  5. The Small RNA ncS35 Regulates Growth in Burkholderia cenocepacia J2315
  6. Elucidation of the mechanism behind the potentiating activity of baicalin against Burkholderia cenocepacia biofilms
  7. Identification of small RNAs abundant in Burkholderia cenocepacia biofilms reveal putative regulators with a potential role in carbon and iron metabolism
  8. Community Composition Determines Activity of Antibiotics against Multispecies Biofilms
  9. A Topical Hydrogel with Deferiprone and Gallium-Protoporphyrin Targets Bacterial Iron Metabolism and Has Antibiofilm Activity
  10. Metabolic activity, urease production, antibiotic resistance and virulence in dual species biofilms of Staphylococcus epidermidis and Staphylococcus aureus
  11. Screening a repurposing library for potentiators of antibiotics against Staphylococcus aureus biofilms
  12. Effect of β-Lactamase inhibitors on in vitro activity of β-Lactam antibiotics against Burkholderia cepacia complex species
  13. The Role of Reactive Oxygen Species in Antibiotic-Induced Cell Death in Burkholderia cepacia Complex Bacteria
  14. The Role of Efflux and Physiological Adaptation in Biofilm Tolerance and Resistance
  15. Orthopaedic device-related infection: current and future interventions for improved prevention and treatment
  16. Differential Roles of RND Efflux Pumps in Antimicrobial Drug Resistance of Sessile and Planktonic Burkholderia cenocepacia Cells
  17. The Family Burkholderiaceae
  18. Transport of Nanoparticles and Tobramycin-loaded Liposomes in Burkholderia cepacia Complex Biofilms
  19. Evaluation of a new high-throughput method for identifying quorum quenching bacteria
  20. The presence of antibiotic-resistant nosocomial pathogens in endotracheal tube biofilms and corresponding surveillance cultures
  21. Genomewide screening for genes involved in biofilm formation and miconazole susceptibility in Saccharomyces cerevisiae
  22. Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy
  23. Corrigendum to “Synthesis and evaluation of thiazolidinedione and dioxazaborocane analogues as inhibitors of AI-2 quorum sensing in Vibrio harveyi” [Bioorg. Med. Chem. 21 (2013) 660–667]
  24. Comment on: Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model
  25. Biofilm inhibitory and eradicating activity of wound care products againstStaphylococcus aureusandStaphylococcus epidermidisbiofilms in anin vitrochronic wound model
  26. Biofilm-Grown Burkholderia cepacia Complex Cells Survive Antibiotic Treatment by Avoiding Production of Reactive Oxygen Species
  27. Antiseptic cyclodextrin-functionalized hydrogels and gauzes for loading and delivery of benzalkonium chloride
  28. Synthesis and evaluation of thiazolidinedione and dioxazaborocane analogues as inhibitors of AI-2 quorum sensing in Vibrio harveyi
  29. Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems
  30. Susceptibility of adult pigeons and hybrid falcons to experimental aspergillosis
  31. Synthesis and evaluation of the quorum sensing inhibitory effect of substituted triazolyldihydrofuranones
  32. A Quorum Sensing-Disrupting Brominated Thiophenone with a Promising Therapeutic Potential to Treat Luminescent Vibriosis
  33. Assessment of Microbial Diversity in Biofilms Recovered from Endotracheal Tubes Using Culture Dependent and Independent Approaches
  34. Transcription factor Efg1 contributes to the tolerance of Candida albicans biofilms against antifungal agents in vitro and in vivo
  35. The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans
  36. Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds
  37. Phytosphingosine-1-Phosphate Is a Signaling Molecule Involved in Miconazole Resistance in Sessile Candida albicans Cells
  38. Evaluation of Nd:YAG and Er:YAG irradiation, antibacterial photodynamic therapy and sodium hypochlorite treatment on Enterococcus faecalis biofilms
  39. Electrospun cellulose acetate phthalate fibers for semen induced anti-HIV vaginal drug delivery
  40. Isolation and identification of quorum quenching bacteria from environmental samples
  41. Quality control of Saccharomyces boulardii- a response to the Letter of Honraet and Delcour (2011)
  42. Superoxide Dismutases Are Involved in Candida albicans Biofilm Persistence against Miconazole
  43. Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives
  44. In vitro inactivation of endodontic pathogens with Nd:YAG and Er:YAG lasers
  45. Quorum Sensing Inhibitors Increase the Susceptibility of Bacterial Biofilms to Antibiotics In Vitro and In Vivo
  46. Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms
  47. Structure-Activity Relationship of Cinnamaldehyde Analogs as Inhibitors of AI-2 Based Quorum Sensing and Their Effect on Virulence of Vibrio spp
  48. Biofilm inhibition and drug-eluting properties of novel DMAEMA-modified polyethylene and silicone rubber surfaces
  49. Bio-inspired porous SiC ceramics loaded with vancomycin for preventing MRSA infections
  50. In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria
  51. What can be learned from genotyping of fungi?
  52. Vancomycin release from poly(d,l-lactic acid) spray-coated hydroxyapatite fibers
  53. Transport and delivery of antimicrobial agents in Burkholderia biofilms
  54. In vitro and in vivo model systems to study microbial biofilm formation
  55. Functionalization of acrylic hydrogels with α-, β- or γ-cyclodextrin modulates protein adsorption and antifungal delivery
  56. Response of sessile cells to stress: from changes in gene expression to phenotypic adaptation
  57. Quality control of fifteen probiotic products containing Saccharomyces boulardii
  58. Social interactions in theBurkholderia cepaciacomplex: biofilms and quorum sensing
  59. Prevention of Candida albicans Biofilm Formation by Covalently Bound Dimethylaminoethylmethacrylate and Polyethylenimine
  60. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
  61. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air
  62. Cyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitro
  63. Candida albicans biofilm formation on peptide functionalized polydimethylsiloxane
  64. The 285 kDa Bap/RTX hybrid cell surface protein (SO4317) of Shewanella oneidensis MR-1 is a key mediator of biofilm formation
  65. Rapid and Direct Quantification of Viable Candida Species in Whole Blood by Use of Immunomagnetic Separation and Solid-Phase Cytometry
  66. Fungicidal activity of miconazole against Candida spp. biofilms
  67. Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression
  68. Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite
  69. Detection and Quantification of Bacteria and Fungi Using Solid-Phase Cytometry
  70. Membrane Rafts Are Involved in Intracellular Miconazole Accumulation in Yeast Cells
  71. Role of PvdQ in Pseudomonas aeruginosa virulence under iron-limiting conditions
  72. AI-2 quorum-sensing inhibitors affect the starvation response and reduce virulence in several Vibrio species, most likely by interfering with LuxPQ
  73. Inhibition of Candida albicans Biofilm Formation by Antimycotics Released from Modified Polydimethyl Siloxane
  74. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria
  75. Arcobacter thereius sp. nov., isolated from pigs and ducks
  76. Comparison of multiple typing methods for Aspergillus fumigatus
  77. Rapid Detection and Quantification of Aspergillus fumigatus in Environmental Air Samples Using Solid-Phase Cytometry
  78. Effectiveness of different laser systems to killEnterococcus faecalisin aqueous suspension and in an infected tooth model
  79. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium--authors' response
  80. Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia
  81. Detection and quantification of viable airborne bacteria and fungi using solid-phase cytometry
  82. Evaluation of the efficacy of disinfection procedures against Burkholderia cenocepacia biofilms
  83. Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery
  84. Polypropylene grafted with smart polymers (PNIPAAm/PAAc) for loading and controlled release of vancomycin
  85. Use of the modified Robbins device to study thein vitrobiofilm removal efficacy of NitrAdine™, a novel disinfecting formula for the maintenance of oral medical devices
  86. Microsatellite typing of Aspergillus fumigatus isolates recovered from deep organ samples of patients with invasive aspergillosis
  87. Monitoring ALS1 and ALS3 Gene Expression During In Vitro Candida albicans Biofilm Formation Under Continuous Flow Conditions
  88. Diversity and occurrence ofBurkholderiaspp. in the natural environment
  89. High-resolution genotyping of Aspergillus fumigatus isolates recovered from chronically colonised patients with cystic fibrosis
  90. Factors influencing the trailing endpoint observed in Candida albicans susceptibility testing using the CLSI procedure
  91. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium
  92. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates
  93. Enumeration of airborne bacteria and fungi using solid phase cytometry
  94. Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR
  95. Identification of putative noncoding RNA genes in the Burkholderia cenocepacia J2315 genome
  96. Efficacy of silver-releasing rubber for the prevention ofPseudomonas aeruginosabiofilm formation in water
  97. Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors
  98. In Vitro Inhibition of Streptococcus mutans Biofilm Formation on Hydroxyapatite by Subinhibitory Concentrations of Anthraquinones
  99. DNA–DNA hybridization values and their relationship to whole-genome sequence similarities
  100. Pannonibacter phragmitetus, described from a Hungarian soda lake in 2003, had been recognized several decades earlier from human blood cultures as Achromobacter groups B and E
  101. Classification of Centers for Disease Control Group Eugonic Fermenter (EF)-4a and EF-4b as Neisseria animaloris sp. nov. and Neisseria zoodegmatis sp. nov., respectively
  102. Burkholderia mimosarum sp. nov., isolated from root nodules of Mimosa spp. from Taiwan and South America
  103. Chryseobacterium piscium sp. nov., isolated from fish of the South Atlantic Ocean off South Africa
  104. Diversity of Weissella viridescens strains associated with “Morcilla de Burgos”
  105. Streptococcus parauberis associated with modified atmosphere packaged broiler meat products and air samples from a poultry meat processing plant
  106. Transmission of Burkholderia cepacia Complex: Evidence for New Epidemic Clones Infecting Cystic Fibrosis Patients in Italy
  107. Chryseobacterium vrystaatense sp. nov., isolated from raw chicken in a chicken-processing plant
  108. Re-evaluating prokaryotic species
  109. Lactobacillus oligofermentans sp. nov., Associated with Spoilage of Modified-Atmosphere-Packaged Poultry Products
  110. A novel strategy for the isolation and identification of environmental Burkholderia cepacia complex bacteria
  111. Development of a recA Gene-Based Identification Approach for the Entire Burkholderia Genus
  112. Use of PCR Analyses To Define the Distribution of Ralstonia Species Recovered from Patients with Cystic Fibrosis
  113. Displacement of ɛ-proteobacterial core genes by horizontally transferred homologous genes
  114. Burkholderia phytofirmans sp. nov., a novel plant-associated bacterium with plant-beneficial properties
  115. Towards a prokaryotic genomic taxonomy
  116. Arcobacter cibarius sp. nov., isolated from broiler carcasses
  117. Organisation of the S10 , spc and alpha ribosomal protein gene clusters in prokaryotic genomes
  118. Characterization of Mononucleotide Repeats in Sequenced Prokaryotic Genomes
  119. Advenella incenata gen. nov., sp. nov., a novel member of the Alcaligenaceae, isolated from various clinical samples
  120. Burkholderia phenoliruptrix sp. nov., to Accommodate the 2,4,5-Trichlorophenoxyacetic Acid and Halophenol-Degrading Strain AC1100
  121. Polyphasic Characterisation of Burkholderia cepacia-Like Isolates Leading to the Emended Description of Burkholderia pyrrocinia
  122. Genome Update: correlation of bacterial genomic properties
  123. Taxonomy of the genus Cupriavidus: a tale of lost and found
  124. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe
  125. Enterococcus hermanniensis sp. nov., from modified-atmosphere-packaged broiler meat and canine tonsils
  126. Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993
  127. Bacterial whole-genome sequences: minimal information and strain availability
  128. PCR-Based Assay for Differentiation of Pseudomonas aeruginosa from Other Pseudomonas Species Recovered from Cystic Fibrosis Patients
  129. Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov.
  130. Genome Update: rRNAs in sequenced microbial genomes
  131. Identification of genomic groups in the genus Stenotrophomonas using gyrB RFLP analysis
  132. Use of the Genomic Signature in Bacterial Classification and Identification
  133. A Genomic Perspective on the Relationship Between the Aquificales and the e-Proteobacteria
  134. Extracting phylogenetic information from whole-genome sequencing projects: the lactic acid bacteria as a test case
  135. Intragenomic heterogeneity between multiple 16S ribosomal RNA operons in sequenced bacterial genomes
  136. Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Ruger and Tan 1983 as Achromobacter denitrificans comb. nov.
  137. Achromobacter insolitus sp. nov. and Achromobacter spanius sp. nov., from human clinical samples
  138. Diversity and significance of Burkholderia species occupying diverse ecological niches
  139. Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients
  140. Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov.
  141. Identification by Subtractive Hybridization of a Novel Insertion Element Specific for Two Widespread Burkholderia cepacia Genomovar III Strains
  142. Updated Version of the Burkholderia cepacia Complex Experimental Strain Panel
  143. Burkholderia cenocepacia sp. nov.—a new twist to an old story
  144. Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes
  145. Molecular epidemiology of Burkholderia species
  146. Comparative Assessment of Genotyping Methods for Epidemiologic Study of Burkholderia cepacia Genomovar III
  147. Characterization of Unusual Bacteria Isolated from Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus limosus gen. nov., sp. nov.
  148. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia , two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools
  149. An epidemic Burkholderia cepacia complex strain identified in soil
  150. Multilocus Restriction Typing: A Novel Tool for Studying Global Epidemiology of Burkholderia cepacia Complex Infection in Cystic Fibrosis
  151. Ribosomal DNA-Directed PCR for Identification of Achromobacter (Alcaligenes) xylosoxidans Recovered from Sputum Samples from Cystic Fibrosis Patients
  152. Characterization of Pseudoalteromonas citrea and P. nigrifaciens Isolated from Different Ecological Habitats Based on REP-PCR Genomic Fingerprints
  153. Identification of Pandoraea Species by 16S Ribosomal DNA-Based PCR Assays
  154. Taxonomy and Identification of the Burkholderia cepacia Complex
  155. Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia Complex
  156. Burkholderia cepacia Genomovar III Is a Common Plant-Associated Bacterium
  157. First report of Pandoraea norimbergensis isolated from food—potential clinical significance
  158. Misidentification of Burkholderia cepacia in US Cystic Fibrosis Treatment Centers